Literature DB >> 25812701

Multiple sclerosis and immunological-related risk factors: results from a case-control study.

Mohammad Mahdi Eftekharian1, Mehrnoush Mousavi2, Mona Bahmani Hormoz2, Ghodratollah Roshanaei3, Mehrdokht Mazdeh4.   

Abstract

AIM: Multiple sclerosis is a demyeliting autoimmune inflammatory disorder of central nervous system (CNS) with unknown etiology, which afflicts more than 2.5 millions of the world's population. The aim of this study was to investigate the association between some immunological-related risk factors (tonsillectomy, appendectomy and hepatitis B vaccination) and multiple sclerosis in 2014 in Hamadan city, west of Iran.
METHODS: As a case-control study, data of filled questionnaire with written consents from 250 patients and 250 age and sex matched controls, were collected and analyzed using SPSS version 16 software and Logistic regression test.
RESULTS: In both groups, the case and the control, with average age of 33 years, 70% of the participants were women. Statistical analysis showed that there was no significant association between tonsillectomy and appendectomy with the multiple sclerosis (p > 0.05). Also hepatitis B vaccination did not increase the risk of MS significantly (p > 0.05), although there was a trend toward more vaccination rate in the patients.
CONCLUSION: Considering previous global investigations on this topic with the result of our study, it seems more studies are needed to determine the definitive association between tonsillectomy, appendectomy and hepatitis B vaccination with multiple sclerosis.

Entities:  

Keywords:  Multiple sclerosis; appendectomy; hepatitis B vaccine; risk factors; tonsillectomy

Mesh:

Year:  2014        PMID: 25812701     DOI: 10.3233/HAB-150281

Source DB:  PubMed          Journal:  Hum Antibodies        ISSN: 1093-2607


  9 in total

Review 1.  [Multiple sclerosis and hepatitis B vaccination : What does the verdict of the European Court of Justice on liability after vaccination mean?]

Authors:  M Löbermann; B Handorn; A Winkelmann; E C Reisinger; H P Hartung; U K Zettl
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

2.  The Multiple Sclerosis Self-Management Scale-Revised (MSSM-R): Persian Version and Psychometric Analysis.

Authors:  Sajjad Saadat; Mohammad Bagher Kajbaf; Mehrdad Kalantari; Mozaffar Hosseininezhad
Journal:  Int J MS Care       Date:  2020 Jan-Feb

Review 3.  Vaccines and multiple sclerosis: a systematic review.

Authors:  Mia Topsøe Mailand; Jette Lautrup Frederiksen
Journal:  J Neurol       Date:  2016-09-07       Impact factor: 6.682

4.  HBV vaccine and risk of developing multiple sclerosis: a systematic review and meta-analysis.

Authors:  Cristina Sestili; Inês Grazina; Giuseppe La Torre
Journal:  Hum Vaccin Immunother       Date:  2021-07-03       Impact factor: 4.526

5.  Central Demyelinating Diseases after Vaccination Against Hepatitis B Virus: A Disproportionality Analysis within the VAERS Database.

Authors:  Julie Mouchet; Bernard Bégaud
Journal:  Drug Saf       Date:  2018-08       Impact factor: 5.228

6.  The Effect of Continuous Care on the Lifestyle of Patients with Multiple Sclerosis: A Randomized Clinical Trial.

Authors:  Masoud Khodaveisi; Fatemah Ashtarani; Ali Beikmoradi; Nahid Mohammadi; Hossein Mahjub; Mehrdokht Mazdeh; Elham Ashtarani
Journal:  Iran J Nurs Midwifery Res       Date:  2017 May-Jun

Review 7.  Vaccination in Multiple Sclerosis: Friend or Foe?

Authors:  Tobias Zrzavy; Herwig Kollaritsch; Paulus S Rommer; Nina Boxberger; Micha Loebermann; Isabella Wimmer; Alexander Winkelmann; Uwe K Zettl
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

Review 8.  Interpretation of vaccine associated neurological adverse events: a methodological and historical review.

Authors:  Marija Cauchi; Harriet Ball; Yoav Ben-Shlomo; Neil Robertson
Journal:  J Neurol       Date:  2021-08-16       Impact factor: 4.849

9.  Risk Factors Associated with Multiple Sclerosis: A Case-Control Study in Damascus, Syria.

Authors:  Maher Taan; Farah Al Ahmad; Mohammad Karim Ercksousi; Ghassan Hamza
Journal:  Mult Scler Int       Date:  2021-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.